下载App
扫码立即下载
  • 下载App

    扫码立即下载

  • 在线客服

    登录后咨询在线客服
+
恭喜您!
成功领取价值超 5000港元/年的高级行情
前往体验 >>

Progyny (NASDAQ:PGNY) Updates FY 2022 Earnings Guidance
Progyny(纳斯达克股票代码:PGNY)更新2022财年收益指引

Financial News Live ·  {{timeTz}}

Progyny (NASDAQ:PGNY – Get Rating) issued an update on its FY 2022 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $0.14-$0.19 for the period, compared to the consensus estimate of $0.09. The company issued revenue guidance of $750.00 million-$775.00 million, compared to the consensus revenue estimate of $756.81 million. Progyny also updated its FY22 guidance to $0.14-$0.19 EPS.

周四上午,普罗吉尼(纳斯达克代码:PGNY-GET Rating)发布了2022财年最新收益指引。该公司提供了该季度每股收益(EPS)0.14-0.19美元的指引,而普遍预期为0.09美元。该公司发布的营收指引为7.5亿至7.75亿美元,而市场普遍预期的营收为7.5681亿美元。Progyny还将其22财年每股收益指引更新为0.14-0.19美元。

Progyny Stock Performance

Progyny股票表现

PGNY traded up $11.38 on Friday, hitting $41.15. 3,469,925 shares of the company were exchanged, compared to its average volume of 684,594. The stock has a market capitalization of $3.78 billion, a PE ratio of 89.46, a price-to-earnings-growth ratio of 21.71 and a beta of 1.85. Progyny has a 12 month low of $25.67 and a 12 month high of $68.32. The firm has a fifty day simple moving average of $30.23 and a two-hundred day simple moving average of $37.32.

上周五,纽约商品交易所股价上涨11.38美元,触及41.15美元。该公司的股票成交量为3469,925股,而其平均成交量为684,594股。该股市值为37.8亿美元,市盈率为89.46倍,市盈率为21.71倍,贝塔系数为1.85。Progyny的12个月低点为25.67美元,12个月高位为68.32美元。该公司的50日简单移动均线为30.23美元,200日简单移动均线为37.32美元。

Get
到达
Progyny
孕期
alerts:
警报:

Progyny (NASDAQ:PGNY – Get Rating) last issued its quarterly earnings data on Thursday, August 4th. The company reported $0.09 earnings per share for the quarter, topping analysts' consensus estimates of $0.05 by $0.04. The firm had revenue of $195.00 million for the quarter, compared to analyst estimates of $190.51 million. Progyny had a return on equity of 18.11% and a net margin of 7.39%. The business's quarterly revenue was up 51.5% compared to the same quarter last year. During the same period last year, the company earned $0.19 EPS. On average, equities analysts expect that Progyny will post 0.17 earnings per share for the current year.

纳斯达克上一次发布季度收益数据是在8月4日星期四。该公司公布本季度每股收益为0.09美元,比分析师普遍预期的0.05美元高出0.04美元。该公司本季度营收为1.95亿美元,而分析师预期为1.9051亿美元。Progyny的股本回报率为18.11%,净利润率为7.39%。与去年同期相比,该业务的季度收入增长了51.5%。去年同期,该公司每股收益为0.19美元。股票分析师平均预计,Progyny本年度每股收益将为0.17美元。

Insider Activity

内幕活动

In other Progyny news, Director Norman Payson sold 6,618 shares of Progyny stock in a transaction on Wednesday, May 11th. The stock was sold at an average price of $33.45, for a total transaction of $221,372.10. Following the completion of the transaction, the director now owns 490,828 shares in the company, valued at $16,418,196.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Norman Payson sold 6,618 shares of Progyny stock in a transaction on Wednesday, May 11th. The stock was sold at an average price of $33.45, for a total value of $221,372.10. Following the completion of the sale, the director now owns 490,828 shares of the company's stock, valued at $16,418,196.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman David J. Schlanger sold 1,452 shares of the business's stock in a transaction dated Monday, June 27th. The shares were sold at an average price of $31.21, for a total value of $45,316.92. Following the sale, the chairman now directly owns 82,548 shares of the company's stock, valued at approximately $2,576,323.08. The disclosure for this sale can be found here. Insiders sold a total of 41,240 shares of company stock worth $1,291,601 in the last quarter. 14.00% of the stock is owned by company insiders.
在Progyny的其他消息中,董事诺曼·佩森在5月11日星期三的一笔交易中出售了6618股Progyny股票。该股以33.45美元的平均价格出售,总成交金额为221,372.10美元。交易完成后,董事现在拥有该公司490,828股,价值16,418,196.60美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,可以通过以下链接访问该文件。在相关新闻中,董事诺曼·佩森在5月11日星期三的一次交易中出售了6,618股Progyny股票。这只股票的平均售价为33.45美元,总价值为221,372.10美元。出售完成后,董事现在拥有490,828股该公司股票,价值16,418,196.60美元。这笔交易是在提交给美国证券交易委员会(Securities&Exchange Commission)的一份文件中披露的,可以通过这个超级链接访问。此外,董事长大卫·J·施兰格在6月27日星期一的交易中出售了1,452股该公司股票。这些股票的平均价格为31.21美元,总价值为45316.92美元。出售后,董事长现在直接拥有82,548股公司股票,价值约2,576,323.08美元。此次拍卖的披露信息可在此处找到。上个季度,内部人士总共出售了41,240股公司股票,价值1,291,601美元。14.00%的股份由公司内部人士持有。

Institutional Inflows and Outflows

机构资金流入和流出

Several hedge funds and other institutional investors have recently bought and sold shares of PGNY. Clearbridge Investments LLC boosted its position in Progyny by 2.7% during the 1st quarter. Clearbridge Investments LLC now owns 3,223,502 shares of the company's stock valued at $165,688,000 after acquiring an additional 86,249 shares in the last quarter. State Street Corp raised its stake in shares of Progyny by 4.0% during the 1st quarter. State Street Corp now owns 2,075,678 shares of the company's stock valued at $106,690,000 after buying an additional 80,100 shares during the last quarter. Dai Ichi Life Insurance Company Ltd purchased a new position in shares of Progyny during the 1st quarter valued at about $3,069,000. Owls Nest Partners IA LLC grew its position in shares of Progyny by 9.8% during the 1st quarter. Owls Nest Partners IA LLC now owns 601,387 shares of the company's stock valued at $30,911,000 after acquiring an additional 53,836 shares during the period. Finally, Vanguard Group Inc. grew its position in shares of Progyny by 0.8% during the 1st quarter. Vanguard Group Inc. now owns 6,525,283 shares of the company's stock valued at $335,399,000 after acquiring an additional 49,779 shares during the period. Institutional investors own 82.51% of the company's stock.

几家对冲基金和其他机构投资者最近买卖了PGNY的股票。ClearBridge Investments LLC在第一季度将其在Progyny的头寸增加了2.7%。ClearBridge Investments LLC在上个季度增持了86,249股后,现在拥有3,223,502股该公司股票,价值165,688,000美元。道富银行在第一季度增持了4.0%的Progyny股票。道富银行目前持有该公司2,075,678股股票,价值106,690,000美元,此前该公司在上个季度又购买了80,100股票。第一季度,Dai Ichi Life Insurance Company Ltd购买了Progyny的新股票头寸,价值约3,069,000美元。Ols Nest Partners IA LLC在第一季度将其在Progyny的股票头寸增加了9.8%。Ols Nest Partners IA LLC在此期间增持了53,836股,目前拥有601,387股该公司股票,价值30,911,000美元。最后,先锋集团(Vanguard Group Inc.)在第一季度将其在Progyny的股票头寸增加了0.8%。先锋集团在此期间增持了49,779股,目前持有该公司6,525,283股股票,价值335,399,000美元。机构投资者持有该公司82.51%的股份。

About Progyny

关于Progyny

(Get Rating)

(获取评级)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Progyny,Inc.是一家福利管理公司,专门为美国雇主提供生育和家庭建设福利解决方案。其生育福利解决方案包括差异化福利计划设计、个性化礼宾式会员支持服务和有选择的生育专家网络。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on Progyny (PGNY)
  • MarketBeat: Week in Review 8/1 – 8/5
  • How to Use High Beta Stocks to Maximize Your Investing Profits
  • Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
  • Why Apple Could Be At All-Time Highs By Year End
  • Beyond Meat Is Not Beyond Hope, And It's Cheap
  • 免费获取StockNews.com关于Progyny的研究报告(PGNY)
  • MarketBeat:回顾中的一周8/1-8/5
  • 如何利用高贝塔系数股票最大化你的投资利润
  • 克罗诺斯集团(Cronos Group Inc.)营收上升,是时候收购了吗?
  • 苹果为何可能在年底创下历史新高
  • Beyond Meat不是没有希望,而且它很便宜

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.

接受Progyny Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Progyny和相关公司的最新新闻和分析师评级的每日简要摘要。

本页的译文内容由软件翻译。富途将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。

风险提示:以上内容仅作为作者或者嘉宾的观点,不代表富途的任何立场,不构成与富途相关的任何投资建议。在作出任何投资决定前,投资者应根据自身情况考虑投资产品相关的风险因素,并于需要时咨询专业投资顾问意见。富途竭力但不能证实上述内容的真实性、准确性和原创性,对此富途不做任何保证和承诺。